From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

ανά DeFronzo, Ralph A.
Έκδοση 2009

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

ανά DeFronzo, Ralph A.
Έκδοση 2011

The EMPA-REG study: What has it told us?: A diabetologist’s perspective

ανά DeFronzo, Ralph A.
Τόπος έκδοσης J Diabetes Complications (2015)

COMBINATION THERAPY WITH GLP-1 RECEPTOR AGONIST AND SGLT2 INHIBITOR

ανά DeFronzo, Ralph A.
Τόπος έκδοσης Diabetes Obes Metab (2017)

Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type

ανά Miyazaki, Yoshinori, DeFronzo, Ralph A
Έκδοση 2009

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

ανά DeFronzo, Ralph A., Tripathy, Devjit
Έκδοση 2009

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!

ανά Schwartz, Stanley, DeFronzo, Ralph A.
Έκδοση 2013

A novel experimental model for human mixed acinar–ductal pancreatic cancer

ανά Doiron, Bruno, DeFronzo, Ralph A
Τόπος έκδοσης Carcinogenesis (2018)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

ανά DeFronzo, Ralph A., Abdul-Ghani, Muhammad
Έκδοση 2011

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm

ανά Abdul-Ghani, Muhammad, DeFronzo, Ralph A.
Τόπος έκδοσης Diabetes Care (2017)

Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents

ανά Di Pino, Antonino, DeFronzo, Ralph A
Τόπος έκδοσης Endocr Rev (2019)

Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken

ανά Abdul-Ghani, Muhammad, DeFronzo, Ralph A
Τόπος έκδοσης J Clin Endocrinol Metab (2021)

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes

ανά Abdul-Ghani, Muhammad A., DeFronzo, Ralph A.
Έκδοση 2009

Pathogenesis of Insulin Resistance in Skeletal Muscle

ανά Abdul-Ghani, Muhammad A., DeFronzo, Ralph A.
Έκδοση 2010

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

ανά Triplitt, Curtis, Cersosimo, Eugenio, DeFronzo, Ralph A
Έκδοση 2010

Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult Mice

ανά Doiron, Bruno, Hu, Wenchao, DeFronzo, Ralph A.
Τόπος έκδοσης Curr Pharm Biotechnol (2016)

Dapagliflozin for the treatment of type 2 diabetes

ανά Abdul-Ghani, Muhammad A, DeFronzo, Ralph A
Τόπος έκδοσης Expert Opin Pharmacother (2013)

Lowering Plasma Glucose Concentration by Inhibiting Renal Sodium-Glucose Co-Transport

ανά Abdul-Ghani, Muhammad A, DeFronzo, Ralph A
Τόπος έκδοσης J Intern Med (2014)

Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302

ανά Gastaldelli, Amalia, DeFronzo, Ralph A., Salehi, Marzieh
Τόπος έκδοσης Diabetes Care (2021)

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

ανά DeFronzo, Ralph A., Eldor, Roy, Abdul-Ghani, Muhammad
Έκδοση 2013